Eagle Pharmaceuticals (NASDAQ:EGRX) is a specialty pharmaceutical company focused on developing and commercializing critical care and oncology products. Using its proprietary technology, Eagle works to improve existing formulations, enhancing the effectiveness and accessibility of medicines for patients in need. The company's portfolio includes innovative treatments for acute pain, cancer support care, and critical care products. Eagle Pharmaceuticals is dedicated to making its pharmaceuticals more effective while maintaining safety and convenience for patients. Its objectives include continuing to expand its product line through both in-house development and strategic partnerships, aiming to address unmet medical needs in the healthcare sector.